Literature DB >> 29722955

Increased Iron Deposition on Brain Quantitative Susceptibility Mapping Correlates with Decreased Cognitive Function in Alzheimer's Disease.

Lei Du1, Zifang Zhao2, Ailing Cui3, Yijiang Zhu4, Lu Zhang5, Jing Liu1, Sumin Shi1, Chao Fu1, Xiaowei Han1, Wenwen Gao1, Tianbin Song6, Lizhi Xie7, Lei Wang8, Shilong Sun1, Runcai Guo1, Guolin Ma1.   

Abstract

The excessive accumulation of iron in deep gray structures is an important pathological characteristic in patients with Alzheimer's disease (AD). Quantitative susceptibility mapping (QSM) is more specific than other imaging-based iron measurement modalities and allows noninvasive assessment of tissue magnetic susceptibility, which has been shown to correlate well with brain iron levels. This study aimed to investigate the correlations between the magnetic susceptibility values of deep gray matter nuclei and the cognitive functions assessed by mini-mental state examination (MMSE) and Montreal cognitive assessment (MoCA) in patients with mild and moderate AD. Thirty subjects with mild and moderate AD and 30 age- and sex-matched healthy controls were scanned with a 3.0 T magnetic resonance imaging (MRI) scanner. The magnetic susceptibilities of the regions of interest (ROIs), including caudate nucleus (Cd), putamen (Pt), globus pallidus (Gp), thalamus (Th), red nucleus (Rn), substantia nigra (Sn), and dentate nucleus (Dn), were quantified by QSM. We found that the susceptibility values of the bilateral Cd and Pt were significantly higher in AD patients than the controls ( P < 0.05). In contrast, bilateral Rn had significantly lower susceptibility values in AD than the controls. Regardless of gender and age, the increase of magnetic susceptibility in the left Cd was significantly correlated with the decrease of MMSE scores and MoCA scores ( P < 0.05). Our study indicated that magnetic susceptibility value of left Cd could be potentially used as a biomarker of disease severity in mild and moderate AD.

Entities:  

Keywords:  Alzheimer’s disease; Montreal cognitive assessment; cognitive function; deep gray matter nuclei; mini-mental state examination; quantitative susceptibility mapping

Mesh:

Substances:

Year:  2018        PMID: 29722955     DOI: 10.1021/acschemneuro.8b00194

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  29 in total

Review 1.  Treating Alzheimer's disease by targeting iron.

Authors:  Sara Nikseresht; Ashley I Bush; Scott Ayton
Journal:  Br J Pharmacol       Date:  2019-02-11       Impact factor: 8.739

2.  Alterations in brain iron deposition with progression of late-life depression measured by magnetic resonance imaging (MRI)-based quantitative susceptibility mapping.

Authors:  Fang Wang; Ming Zhang; Yan Li; Yufei Li; Hengfen Gong; Jun Li; Yuyao Zhang; Chencheng Zhang; Fuhua Yan; Bomin Sun; Naying He; Hongjiang Wei
Journal:  Quant Imaging Med Surg       Date:  2022-07

Review 3.  Early differentiation of neurodegenerative diseases using the novel QSM technique: what is the biomarker of each disorder?

Authors:  Farzaneh Nikparast; Zohreh Ganji; Hoda Zare
Journal:  BMC Neurosci       Date:  2022-07-28       Impact factor: 3.264

4.  Tip60/Kat5 may be a novel candidate histone acetyltransferase for the regulation of liver iron localization via acetylation.

Authors:  Nurdan Gönül Baltacı; Emine Toraman; Mesut Akyüz; Şeyda Nur Kalın; Harun Budak
Journal:  Biometals       Date:  2022-08-20       Impact factor: 3.378

Review 5.  The Key Role of Magnetic Resonance Imaging in the Detection of Neurodegenerative Diseases-Associated Biomarkers: A Review.

Authors:  Ke-Ru Li; An-Guo Wu; Yong Tang; Xiao-Peng He; Chong-Lin Yu; Jian-Ming Wu; Guang-Qiang Hu; Lu Yu
Journal:  Mol Neurobiol       Date:  2022-07-12       Impact factor: 5.682

Review 6.  Cerebral Iron Deposition in Neurodegeneration.

Authors:  Petr Dusek; Tim Hofer; Jan Alexander; Per M Roos; Jan O Aaseth
Journal:  Biomolecules       Date:  2022-05-17

Review 7.  The Role of Microglia in Alzheimer's Disease From the Perspective of Immune Inflammation and Iron Metabolism.

Authors:  Hui-Zhi Long; Zi-Wei Zhou; Yan Cheng; Hong-Yu Luo; Feng-Jiao Li; Shuo-Guo Xu; Li-Chen Gao
Journal:  Front Aging Neurosci       Date:  2022-06-30       Impact factor: 5.702

8.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

Review 9.  Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer's Disease, Parkinson's Disease, and Intracerebral Hemorrhage.

Authors:  Amy Corbin Farr; May P Xiong
Journal:  Mol Pharm       Date:  2020-10-09       Impact factor: 4.939

Review 10.  Iron and Ferroptosis as Therapeutic Targets in Alzheimer's Disease.

Authors:  Andrew Gleason; Ashley I Bush
Journal:  Neurotherapeutics       Date:  2020-10-27       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.